| Status | Study |
| Recruiting |
Study Name: Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy Condition: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Date: 2014-02-24 Interventions: Drug: eltrombopag olamine Given PO Other Names: |
| Active, not recruiting |
Study Name: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukem Date: 2012-06-21 Interventions: Drug: Cytarabine Given IV |
| Terminated |
Study Name: Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukem Date: 2012-03-07 Interventions: Drug: eltrombopag olamine Give |
| Completed |
Study Name: Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 Condition: Leukemia Date: 2011-07-30 Interventions: Genetic: DNA analysis Genetic: gene expres |
| Terminated |
Study Name: Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia Condition: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Adult Date: 2010-12-14 Interventions: Drug: Azacitidine Given SC |
| Terminated |
Study Name: Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukem Date: 2010-07-08 Interventions: Drug: entinostat Given orally |
| Completed |
Study Name: Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia Condition: Childhood Acute Basophilic Leukemia Childhood Acute Eosinophili Date: 2010-02-25 Interventions: Other: laboratory biomarker analysis Correlative studies |
| Completed |
Study Name: Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia Condition: Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Date: 2008-04-24 Interventions: Drug: idarubicin Given IV |
| Completed |
Study Name: Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukem Date: 2006-12-04 Interventions: Drug: alvocidib Given IV |
| Completed |
Study Name: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase Condition: Adult Acute Basophilic Leukemia Adult Acute Eosinophilic Leukem Date: 2006-09-29 Interventions: Drug: Bortezomib Given IV |